OOIR: Observatory of International Research

Papers

(The TQCC of Clinical and Translational Allergy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Non‐specific lipid‐transfer proteins: Allergen structure and function, cross‐reactivity, sensitization, and epidemiology	76
Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution	66
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies	52
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)	41
Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma	39
Initiating pollen sensitization – complex source, complex mechanisms	37
IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis	35
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®	33
Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up	31
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study	31
Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma	30
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paper	30
Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab	29
The applications of eHealth technologies in the management of asthma and allergic diseases	29
Role of IL‐17 in atopy—A systematic review	28
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemic	27
Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa	27
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy	26
Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study	24
Comorbidities in hereditary angioedema—A population‐based cohort study	22
The role of antifungals in the management of patients with severe asthma	21
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs	21
Citrullinated histone H3, a marker of extracellular trap formation, is increased in blood of stable asthma patients	21
The need for Pan‐European automatic pollen and fungal spore monitoring: A stakeholder workshop position paper	20
Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils	20

Food protein‐induced enterocolitis syndrome: A large French multicentric experience	20
A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria	19
Current transition management of adolescents and young adults with allergy and asthma: a European survey	19
Secretory protein beta‐lactoglobulin in cattle stable dust may contribute to the allergy‐protective farm effect	19
Frequency of severe reactions following penicillin drug provocation tests: A Bayesian meta‐analysis	18
Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP	17
Psychological needs and support among patients and families undergoing food oral immunotherapy	16
DNA methylation biomarkers in asthma and rhinitis: Are we there yet?	16
Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta‐analysis	16
Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)	16
Development of childhood asthma prediction models using machine learning approaches	16
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air^®approach	15
Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis	15
Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China	15
Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications	15
Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy	14
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey	14
Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis	14
Apple allergy: Causes and factors influencing fruits allergenic properties–Review	14
En route to personalized medicine: uncovering distinct IgE reactivity pattern to house dust mite components in Brazilian and Austrian allergic patients	14
Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis	13
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)	13
Anomalous asthma and chronic obstructive pulmonary disease Google Trends patterns during the COVID-19 pandemic	13
Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes	13
Increasing incidence of anaphylaxis in Hong Kong from 2009 to 2019—discrepancies of anaphylaxis care between adult and paediatric patients	12
Immunoregulatory effects of Lactococcus lactis‐derived extracellular vesicles in allergic asthma	12
Leptin favors Th17/Treg cell subsets imbalance associated with allergic asthma severity	12
Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium	12
Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features	12
Environmental and sensitization variations among asthma and/or rhinitis patients between 2008 and 2018 in China	12
Gram‐negative microbiota is related to acute exacerbation in children with asthma	12
The basophil activation test differentiates between patients with wheat‐dependent exercise‐induced anaphylaxis and control subjects using gluten and isolated gluten protein types	12
Variation in IgE binding potencies of seven Artemisia species depending on content of major allergens	12
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities	12
Systematic review of monotherapy with biologicals for children and adults with IgE‐mediated food allergy	11
Omalizumab for successful chemotherapy desensitisation: What we know so far	11
Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort	11
Large‐scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma	11
The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries	11
Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis	11
IL‐19 induced by IL‐13/IL‐17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP‐9 expression via ERK/NF‐κB signaling pathway	10
Association of asthma genetic variants with asthma‐associated traits reveals molecular pathways of eosinophilic asthma	10
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model	10
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analys	10
Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria	10
IgE-binding to vicilin-like antimicrobial peptides is associated with systemic reactions to macadamia nut	10
Effects of early‐life exposure to dust mite allergen and endotoxin on the development of asthma and wheezing: The Japan Environment and Children's Study	10
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis	10
Protocol of safe vaccination against COVID‐19 in patients with high risk of allergic reactions	10
A meta‐analysis on allergen‐specific immunotherapy using MCT^® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis	10

Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response	9
Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus	9
Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA)	9
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab	9
Mobile health app for monitoring allergic rhinitis and asthma in real life in Lithuanian MASK‐air users	9
Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence	9
Combinations of self‐reported rhinitis, conjunctivitis, and asthma predicts IgE sensitization in more than 25,000 Danes	9
Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e‐diary AllergyMonitor®	9
Characteristics, mechanism, and management of pain in atopic dermatitis: A literature review	8
Home‐based graded exposure to egg to treat egg allergy	8
Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber	8
Obese asthma phenotypes display distinct plasma biomarker profiles	8
IgE and high‐affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance	8
Adverse events for biologics in patients with CRSwNP: A meta‐analysis	8
Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema	8
Predictors of asthma‐related quality of life in a large cohort of asthmatics: A cross‐sectional study in a secondary care center	8
AllergoOncology: Role of immune cells and immune proteins	8
Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis	8
Highlights and recent developments in allergic diseases in EAACI journals (2019)	8
Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis	8
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?	8
Pru du 1, the Bet v 1‐homologue from almond, is a major allergen in patients with birch pollen associated almond allergy	7
Cross‐reactivity between tick and wasp venom can contribute to frequent wasp sensitization in patients with the α‐Gal syndrome	7
Relationship between longitudinal changes in type‐2 inflammation, immunoglobulin E sensitization, and clinical outcomes in young asthmatics	7
Efficacy and safety of oral immunotherapy for peanut, cow's milk, and hen's egg allergy: A systematic review of randomized controlled trials	7
Heterogeneity of magnitude, allergen immunodominance, and cytokine polarization of cockroach allergen‐specific T cell responses in allergic sensitized children	7
Incidence of anaphylaxis and accidental peanut exposure: A systematic review	7
The value of small airway function parameters and fractional exhaled nitric oxide for predicting positive methacholine challenge test in asthmatics of different ages with FEV₁ ≥ 80% predict	7
Allergic sensitization to lipocalins reflects asthma morbidity in dog dander sensitized children	7
Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study	7
Primary non-adherence to inhaled medications measured with e-prescription data from Poland	7
Comparative short‐term efficacy of endoscopic sinus surgery and biological therapies in chronic rhinosinusitis with nasal polyps: A network meta‐analysis	7
Contact allergens in moisturizers in preventative emollient therapy – A systematic review	7
Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper	7
The health economic impact of cow's milk allergy in childhood: A retrospective cohort study	7
Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports	7